ACPE UAN #: 0233-0000-19-016-H04-P
Release Date: March 25, 2019
Expiration Date: March 25, 2022
Activity Type: Knowledge-based
Contact Hours: 1
Activity Fee: Member: $15 Non-Member: $30
Target Audience: Pharmacists who practice in managed care settings.
The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders, including their impact on pharmacy spend, potential unknown adverse events, and best practices for managing these products over the life of the patient. During this panel discussion, participants will have the opportunity to hone in on pressing issues raised throughout the conference and discuss these issues with a panel of experts with varying backgrounds, including both clinical and managed care perspectives.
At the completion of this activity, participants should be able to:
- Describe how key issues related to the development of gene therapy may impact a variety of stakeholders.
- Discuss the potential place for gene therapy among a number of novel therapeutics recently approved or in the drug development pipeline.
- Discuss the unique requirements for patient follow-up and surveillance for potential adverse events.
Schedule of Educational Activity
This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Specialty Connect 2019.
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Statement of Commercial Support
This educational activity is supported by independent educational grants from AveXis Inc., Genzyme Corporation, Pfizer and Sarepta Therapeutics.
Clifford Goodman, PhD | Senior Vice President & Director | Lewin Center for Comparative Effectiveness Research | Falls Church, Virginia.
System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-19-016-H04-P||1 Contact Hour||March 25, 2019 - March 25, 2022|